Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
IRulya Therapeutics Inc. (IRLA) is the issuer for which SilverArc Capital Management, LLC and Devesh Gandhi reported beneficial ownership of 880,255 shares as of September 30, 2026, or 7.9% of the class. The reported amount comprises 586,836 common shares and 293,419 shares represented by exercisable warrants. Each reporting person reported shared voting and dispositive power over 880,255 shares, with zero sole voting or dispositive power.
The percentage calculation uses 10,841,470 common shares outstanding reported in IRulya's October 9, 2026 Form 8-K and assumes exercise of the warrants. The warrants may not be exercised if doing so would cause the holder and its affiliates to beneficially own more than 9.99% of the then-outstanding common stock.
Key Figures
Beneficial ownership:880,255 sharesCommon shares:586,836 sharesShares represented by exercisable warrants:293,419 shares+3 more
6 metrics
Beneficial ownership880,255 sharesReported by SilverArc Capital Management, LLC and Devesh Gandhi; 7.9% of the class
Common shares586,836 sharesComponent of the reported beneficial ownership
Shares represented by exercisable warrants293,419 sharesComponent of the reported beneficial ownership
Ownership percentage7.9%Calculated assuming exercise of warrants
Common shares outstanding10,841,470 sharesReported in IRulya's October 9, 2026 Form 8-K and used in the ownership-percentage calculation
Warrant exercise limit9.99%Warrants may not be exercised if the holder and its affiliates would exceed this beneficial-ownership percentage
Beneficially owned describes securities or assets where a person has the economic rights and control—such as the right to receive dividends and to direct voting—even if legal title is held in another name. Think of it like having the keys and using a car that’s registered to someone else: you get the benefits and make decisions. Investors care because beneficial ownership reveals who truly controls value and voting power, affecting corporate decisions and takeover dynamics.
shared voting powerregulatory
"Shared Voting Power 880,255.00"
Shared voting power occurs when two or more parties jointly have the right to vote or decide how a block of company shares is cast, like co-owners who must agree before moving a piece of furniture. Investors care because who controls voting rights affects board elections, major corporate decisions and takeover outcomes, and shared control can alter regulatory disclosures and the practical influence any holder has over a company’s direction and value.
shared dispositive powerregulatory
"Shared Dispositive Power 880,255.00"
exercisable warrantsfinancial
"an additional 293,419 in exercisable warrants"
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
How many IRLA shares do SilverArc Capital Management and Devesh Gandhi beneficially own?
They reported beneficial ownership of 880,255 shares, comprising 586,836 common shares and 293,419 shares represented by exercisable warrants. The reported amount equaled 7.9% of the class.
What limit applies to exercise of the IRLA warrants reported by SilverArc?
The warrants may not be exercised if doing so would cause the holder, together with its affiliates, to beneficially own more than 9.99% of IRulya's then-outstanding common stock.
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
UNDER THE SECURITIES EXCHANGE ACT OF 1934
IRulya Therapeutics Inc
(Name of Issuer)
Class A Common Stock
(Title of Class of Securities)
22053A305
(CUSIP Number)
09/30/2026
(Date of Event Which Requires Filing of this Statement)
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
Rule 13d-1(b)
Rule 13d-1(c)
Rule 13d-1(d)
schemaVersion:
SCHEDULE 13G
CUSIP Number(s):
22053A305
1
Names of Reporting Persons
SilverArc Capital Management, LLC
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
DELAWARE
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
880,255.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
880,255.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
880,255.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.9 %
12
Type of Reporting Person (See Instructions)
IA
SCHEDULE 13G
CUSIP Number(s):
22053A305
1
Names of Reporting Persons
Devesh Gandhi
2
Check the appropriate box if a member of a Group (see instructions)
(a)
(b)
3
Sec Use Only
4
Citizenship or Place of Organization
UNITED STATES
Number of Shares Beneficially Owned by Each Reporting Person With:
5
Sole Voting Power
0.00
6
Shared Voting Power
880,255.00
7
Sole Dispositive Power
0.00
8
Shared Dispositive Power
880,255.00
9
Aggregate Amount Beneficially Owned by Each Reporting Person
880,255.00
10
Check box if the aggregate amount in row (9) excludes certain shares (See Instructions)
11
Percent of class represented by amount in row (9)
7.9 %
12
Type of Reporting Person (See Instructions)
IN
SCHEDULE 13G
Item 1.
(a)
Name of issuer:
IRulya Therapeutics Inc
(b)
Address of issuer's principal executive offices:
101 College Street, Suite 210, New Haven, CT 06510
Item 2.
(a)
Name of person filing:
SilverArc Capital Management, LLC ("SilverArc") and Devesh Gandhi ("Gandhi" and together with SilverArc, the "Reporting Persons")
(b)
Address or principal business office or, if none, residence:
20 Park Plaza, Suite 620
Boston, MA 02116
(c)
Citizenship:
SilverArc is a Delaware limited liability company. Gandhi is a citizen of the United States.
(d)
Title of class of securities:
Class A Common Stock
(e)
CUSIP Number(s):
22053A305
Item 3.
If this statement is filed pursuant to §§ 240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
(a)
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o);
(b)
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c);
(c)
Insurance company as defined in section 3(a)(19) of the Act (15 U.S.C. 78c);
(d)
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8);
(e)
An investment adviser in accordance with § 240.13d-1(b)(1)(ii)(E);
(f)
An employee benefit plan or endowment fund in accordance with § 240.13d-1(b)(1)(ii)(F);
(g)
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
(h)
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
(i)
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
(j)
A non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J). If filing as a non-U.S. institution in accordance with § 240.13d-1(b)(1)(ii)(J),
please specify the type of institution:
(k)
Group, in accordance with Rule 240.13d-1(b)(1)(ii)(K).
Item 4.
Ownership
(a)
Amount beneficially owned:
880,255
(b)
Percent of class:
7.9 %
(c)
Number of shares as to which the person has:
(i) Sole power to vote or to direct the vote:
0
(ii) Shared power to vote or to direct the vote:
880,255
(iii) Sole power to dispose or to direct the disposition of:
0
(iv) Shared power to dispose or to direct the disposition of:
880,255
Item 5.
Ownership of 5 Percent or Less of a Class.
Not Applicable
Item 6.
Ownership of more than 5 Percent on Behalf of Another Person.
If any other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, such securities, a statement to that effect should be included in response to this item and, if such interest relates to more than 5 percent of the class, such person should be identified. A listing of the shareholders of an investment company registered under the Investment Company Act of 1940 or the beneficiaries of employee benefit plan, pension fund or endowment fund is not required.
SilverArc, an investment adviser registered under Section 203 of the Investment Advisers Act of 1940, is deemed to be the beneficial owner of 880,255 total shares (586,836 shares of common stock and an additional 293,419 in exercisable warrants). The Warrants may not be exercised if such exercise would cause the holder, together with its affiliates, to beneficially own in excess of 9.99% of the number of shares of the Issuer's Common Stock then outstanding.
The percentages reported herein with respect to the Reporting Persons' holdings are calculated based upon on the Issuer's Form 8-K as filed with the Securities and Exchange Commission on October 9, 2026. Noting that there were shares of 10,841,470 Common Stock of the Issuer outstanding and assumes the exercise of the Warrants (subject to the 9.99% blocker).
Item 7.
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on by the Parent Holding Company or Control Person.
Not Applicable
Item 8.
Identification and Classification of Members of the Group.
Not Applicable
Item 9.
Notice of Dissolution of Group.
Not Applicable
Item 10.
Certifications:
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired and are held in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect, other than activities solely in connection with a nomination under § 240.14a-11.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.